The Covid pandemic has been disastrous for the travel sector in general and 15-year-old Cleartrip in particular. A year after it laid off a...

The Corporate Debt Restructuring Proposal was referred to the CDR cell in May 2013 after Arch Pharma Labs was struggling under a debt burde...

Arch rivals are grouping to look for a lasting solution to what external subject experts call “deeply ingrained culture issue”.

The Indian bulk drug industry is in dire straits and their prospects appear bleak unless the government takes immediate steps to support th...

According to analysts, Q4 earnings and global economic situation are likely to decide the course of markets in the near term.

United Bank of India has taken action against four loan defaulters in an attempt to reduce its non-performing loans.

Indian shares are expected to trade in a range. Here is a list of fifteen stocks that are likely to be in action in morning trade today.

Sources said the Japanese group's healthcare company might pick up stake from private equity players invested in Claris or invest in a join...

The question is whether the business per se is attractive for everyone, says Hitesh Sharma, partner and national leader at Ernst & Young.

ICICI Venture, India's largest private equity player, is set to divest its entire stake in I-Ven Pharma Capital, a special purpose vehicle,...

Lupin and Glenmark Pharmaceuticals are leading Indian mid-cap drug makers in exploiting rising demand for medicines in South American natio...

As a proxy fight for the control of drug maker Orchid intensifies in the stock market, a key weapon in founder K Raghavendra Rao’s arsenal ...

A creeping acquisition has begun in the shares of Chennai-based Orchid Chemicals & Pharmaceuticals which has become vulnerable to acquisiti...

For companies big and small CRM has become a necessity - SMEs in particular have realised its vast importance.